ReviewInternational journal of molecular sciences2024

Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy.

Laurent Servais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.